Upload
health2dev
View
3.956
Download
1
Tags:
Embed Size (px)
Citation preview
Shire ADHD Transitions Challenge
Webinar Presentation
Date: February 6th, 2013
On today’s call:
Tom Curatolo
Senior Director, Commercial Strategy
Shire Pharmaceuticals
JL Neptune
Senior Vice President
Health 2.0
Jenn Stone
Challenge Manager
Health 2.0
Agenda for Today’s Meeting
Shire Pharmaceuticals Overview
ADHD Background
Challenge Goals About the Phases
Evaluation Criteria Timeline
Q & A
Shire Pharmaceuticals
Focused Specialty Pharmaceutical Company 2011 Revenues of $4.3 billion
~5,200 employees
Chesterbrook, PA
Specialty Pharmaceuticals
66%
Lexington, MA
Human Genetic Therapies
31%
San Diego, CA
Regenerative Medicine
3%
Shire Pharmaceuticals
We unleash the potential of people affected by Behavioral Health disorders by creating holistic solutions to help them lead better lives
Priorities:
Better address unmet patient needs in ADHD
Diversify beyond Rx Therapy
Vision
Background
About Attention-Deficit/Hyperactivity Disorder (ADHD) In the US, 9.5%* of children and 4.4%† of adults are affected by
ADHD
Characterized by inattention, hyperactivity and impulsivity
Symptoms often manifest differently in adulthood (predominately inattention)
Patients navigate significant transitions during their journey to adulthood: Relationships, school, work
* Based on a 2007 survey of school-aged children (ages 4-17 years) who were reported by their parents to have ever been diagnosed with ADHD. ���† Based on a survey of US adults ages 18-44 years.
Challenge Goals
Areas to address
Transition from high-school to college
Transition from college to the workforce
Daily organizational and life management challenges
Connection with the healthcare system and encouragement of medication adherence
The Challenge
Phase I – Ideation Submission requirements: concept mock-up and documentation Awards: Five finalists awarded $5,000 each and continue to
Phase II
Phase II – Development Eligibility: Phase I finalist Submission requirements: demo video, slide deck, and app (if
provisional winner) Awards: First Place $100,000, Second Place $20,000, Third
Place $5,000
Evaluation Criteria
Phase I Potential impact to improve the quality of life for application
users. Potential to connect users to health resources
Design, usability and intuitiveness of application
Creativity and innovation
Market potential and opportunity for commercialization
Evaluation Criteria
Phase II Technical Development (i.e. Complexity and functionality of
what was built) Potential impact to improve the quality of life for application
users. Potential to connect users to health resources Design, usability and intuitiveness of application Creativity and innovation Market potential and opportunity for commercialization
Timeline
Phase I submission phase ends: March 17, 2013
Phase II start: August 16, 2013
Phase II end: August 18, 2013
Winners announced:
Health 2.0 Fall 2013 Conference
September 30 - October 2